Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 3/2008

01-03-2008 | Original Paper

Medical Expenditures for Children with an Autism Spectrum Disorder in a Privately Insured Population

Auteurs: Tom T. Shimabukuro, Scott D. Grosse, Catherine Rice

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 3/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

This study provides estimates of medical expenditures for a subset of children and adolescents who receive employer-based health insurance and have a medical diagnosis of an autism spectrum disorder (ASD). Data analyzed were from the 2003 MarketScan® research databases. Individuals with an ASD had average medical expenditures that exceeded those without an ASD by $4,110–$6,200 per year. On average, medical expenditures for individuals with an ASD were 4.1–6.2 times greater than for those without an ASD. Differences in median expenditures ranged from $2,240 to $3,360 per year with median expenditures 8.4–9.5 times greater. These findings add to a growing body of evidence that children and adolescents with medical diagnoses of an ASD incur elevated medical utilization and costs.
Literatuur
go back to reference Aman, M. G., Lam, K. S., & Collier-Crespin, A. (2003). Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders, 33, 527–534.PubMedCrossRef Aman, M. G., Lam, K. S., & Collier-Crespin, A. (2003). Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders, 33, 527–534.PubMedCrossRef
go back to reference Centers for Disease Control, Prevention. (2006). Mental health in the United States: Parental report of diagnosed autism in children aged 4–17 years–United States, 2003–2004. Morbidity and Morality Weekly Report, 55, 481–486. Centers for Disease Control, Prevention. (2006). Mental health in the United States: Parental report of diagnosed autism in children aged 4–17 years–United States, 2003–2004. Morbidity and Morality Weekly Report, 55, 481–486.
go back to reference Croen, L. A., Najjar, D. V., Ray, G. T., Lotspeich, L., & Bernal, P. (2006). A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics, 118, e1203–e1211.PubMedCrossRef Croen, L. A., Najjar, D. V., Ray, G. T., Lotspeich, L., & Bernal, P. (2006). A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics, 118, e1203–e1211.PubMedCrossRef
go back to reference Ganz, M. L. (2006). The costs of autism. In S. O. Moldin, & J. L. R. Rubenstein (Eds.), Understanding autism: From basic neuroscience to treatment, 1st edn. (pp. 475–502). Boca Raton, FL: CRC Press. Ganz, M. L. (2006). The costs of autism. In S. O. Moldin, & J. L. R. Rubenstein (Eds.), Understanding autism: From basic neuroscience to treatment, 1st edn. (pp. 475–502). Boca Raton, FL: CRC Press.
go back to reference Gurney, J. G., McPheeters, M. L., & Davis, M. M. (2006). Parental report of health conditions and health care use among children with and without autism: National Survey of Children’s Health. Archives of Pediatrics & Adolescent Medicine, 160, 825–830.CrossRef Gurney, J. G., McPheeters, M. L., & Davis, M. M. (2006). Parental report of health conditions and health care use among children with and without autism: National Survey of Children’s Health. Archives of Pediatrics & Adolescent Medicine, 160, 825–830.CrossRef
go back to reference Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology, 12, 311–321.PubMedCrossRef Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology, 12, 311–321.PubMedCrossRef
go back to reference Liptak, G. S., Stuart, T., & Auinger, P. (2006). Health care utilization and expenditures for children with autism: Data from U.S. national samples. Journal of Autism and Developmental Disorders, 36, 871–879.PubMedCrossRef Liptak, G. S., Stuart, T., & Auinger, P. (2006). Health care utilization and expenditures for children with autism: Data from U.S. national samples. Journal of Autism and Developmental Disorders, 36, 871–879.PubMedCrossRef
go back to reference Mandell, D. S., Cao, J., Ittenbach, R., & Pinto-Martin, J. (2006). Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999. Journal of Autism and Developmental Disorders, 36, 475–485.PubMedCrossRef Mandell, D. S., Cao, J., Ittenbach, R., & Pinto-Martin, J. (2006). Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999. Journal of Autism and Developmental Disorders, 36, 475–485.PubMedCrossRef
go back to reference Martin, A., Scahill, L., Klin, A., & Volkmar, F.R. (1999). Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 923–931.CrossRef Martin, A., Scahill, L., Klin, A., & Volkmar, F.R. (1999). Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 923–931.CrossRef
go back to reference Newschaffer, C. J., & Curran, L. K. (2003). Autism: An emerging public health problem. Public Health Reports, 118, 393–399.PubMed Newschaffer, C. J., & Curran, L. K. (2003). Autism: An emerging public health problem. Public Health Reports, 118, 393–399.PubMed
go back to reference Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17, 348–355.PubMedCrossRef Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17, 348–355.PubMedCrossRef
go back to reference Ouyang, L., Grosse S. D., Armour, B. S., & Waitzman, N. J. (2007). Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Research Part A: Clinical and Molecular Teratology, 79, 552–558.CrossRef Ouyang, L., Grosse S. D., Armour, B. S., & Waitzman, N. J. (2007). Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Research Part A: Clinical and Molecular Teratology, 79, 552–558.CrossRef
go back to reference Peele, P. B., Lave, J. R., & Kelleher, K.J. (2002). Exclusions and limitations in children’s behavioral health care coverage. Psychiatric Services, 53, 591–594.PubMedCrossRef Peele, P. B., Lave, J. R., & Kelleher, K.J. (2002). Exclusions and limitations in children’s behavioral health care coverage. Psychiatric Services, 53, 591–594.PubMedCrossRef
go back to reference SAS Institute. (2004). SAS 9.1. Cary, NC: Author. SAS Institute. (2004). SAS 9.1. Cary, NC: Author.
go back to reference Thompson Medstat. (2003). MarketScan® research databases user guide and database dictionary. Ann Arbor, MI: Author. Thompson Medstat. (2003). MarketScan® research databases user guide and database dictionary. Ann Arbor, MI: Author.
go back to reference Thompson Medstat. (2004). DataProbe® end user training. Ann Arbor, MI: Author. Thompson Medstat. (2004). DataProbe® end user training. Ann Arbor, MI: Author.
go back to reference Wiggins, L. D., Biao, J., & Rice, C. (2006). Examination of the time between first evaluation and first autism spectrum diagnosis in a population-based sample. Journal of Developmental & Behavioral Pediatrics, 27, S79–S87.CrossRef Wiggins, L. D., Biao, J., & Rice, C. (2006). Examination of the time between first evaluation and first autism spectrum diagnosis in a population-based sample. Journal of Developmental & Behavioral Pediatrics, 27, S79–S87.CrossRef
go back to reference Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. JAMA, 289, 49–55.PubMedCrossRef Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. JAMA, 289, 49–55.PubMedCrossRef
Metagegevens
Titel
Medical Expenditures for Children with an Autism Spectrum Disorder in a Privately Insured Population
Auteurs
Tom T. Shimabukuro
Scott D. Grosse
Catherine Rice
Publicatiedatum
01-03-2008
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 3/2008
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-007-0424-y

Andere artikelen Uitgave 3/2008

Journal of Autism and Developmental Disorders 3/2008 Naar de uitgave